chr11-125654112-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001114122.3(CHEK1):c.1335+265C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.32 in 150,882 control chromosomes in the GnomAD database, including 7,944 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.32   (  7944   hom.,  cov: 31) 
Consequence
 CHEK1
NM_001114122.3 intron
NM_001114122.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.642  
Publications
5 publications found 
Genes affected
 CHEK1  (HGNC:1925):  (checkpoint kinase 1) The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for checkpoint mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA. This protein acts to integrate signals from ATM and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I. Phosphorylation of CDC25A protein phosphatase by this protein is required for cells to delay cell cycle progression in response to double-strand DNA breaks. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2011] 
CHEK1 Gene-Disease associations (from GenCC):
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.411  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.320  AC: 48204AN: 150760Hom.:  7931  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
48204
AN: 
150760
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.320  AC: 48244AN: 150882Hom.:  7944  Cov.: 31 AF XY:  0.320  AC XY: 23558AN XY: 73644 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
48244
AN: 
150882
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
23558
AN XY: 
73644
show subpopulations 
African (AFR) 
 AF: 
AC: 
15380
AN: 
41058
American (AMR) 
 AF: 
AC: 
3737
AN: 
15144
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1069
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
2182
AN: 
5126
South Asian (SAS) 
 AF: 
AC: 
1674
AN: 
4752
European-Finnish (FIN) 
 AF: 
AC: 
3011
AN: 
10314
Middle Eastern (MID) 
 AF: 
AC: 
94
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20346
AN: 
67734
Other (OTH) 
 AF: 
AC: 
642
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1634 
 3267 
 4901 
 6534 
 8168 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 486 
 972 
 1458 
 1944 
 2430 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1241
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.